NCT03224260View on ClinicalTrials.gov

To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 28, 2017

Primary Completion Date

November 7, 2017

Study Completion Date

November 7, 2017

Conditions
Thrombosis
Interventions
DRUG

BMS-986177

Oral Suspension

OTHER

Matched Placebo

Oral Suspension

Trial Locations (1)

90630

West Coast Clinical Trials, Anaheim

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03224260 - To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants | Biotech Hunter | Biotech Hunter